HEADER MEMBRANE PROTEIN 06-NOV-07 2JX4 TITLE NMR STRUCTURE OF THE INTRACELLULAR LOOP (I3) OF THE VASOPRESSIN V2 TITLE 2 RECEPTOR (GPCR) COMPND MOL_ID: 1; COMPND 2 MOLECULE: VASOPRESSIN V2 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 225-273; COMPND 5 SYNONYM: RENAL-TYPE ARGININE VASOPRESSIN RECEPTOR, ANTIDIURETIC COMPND 6 HORMONE RECEPTOR, AVPR V2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: SYNTHESIS UNDER A CYCLIZED FORM: THIO-ETHER BRIDGE COMPND 10 BETWEEN THE C-TERMINAL CYSTEINE RESIDUE (CYC) AND THE N-TERMINAL COMPND 11 GLYCINE WERE CONSTRUCTED SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SOURCE SOURCE 4 SEQUENCE IS NATURALLY FOUND IN RAT (V2 RAT RECEPTOR). KEYWDS PROTEIN, G-PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, KEYWDS 2 MEMBRANE, PALMITATE, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, KEYWDS 3 TRANSMEMBRANE, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.BELLOT,H.DEMENE REVDAT 3 10-NOV-21 2JX4 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2JX4 1 VERSN REVDAT 1 18-NOV-08 2JX4 0 JRNL AUTH G.BELLOT,S.GRANIER,W.BOURGUET,R.SEYER,R.RAHMEH,B.MOUILLAC, JRNL AUTH 2 R.PASCAL,C.MENDRE,H.DEMENE JRNL TITL STRUCTURE OF THE THIRD INTRACELLULAR LOOP OF THE VASOPRESSIN JRNL TITL 2 V2 RECEPTOR AND CONFORMATIONAL CHANGES UPON BINDING TO GC1QR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.0, ARIA 2.0 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), LINGE, REMARK 3 O'DONOGHUE AND NILGES (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JX4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000100400. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308; 318; 293 REMARK 210 PH : 4; 4; 4 REMARK 210 IONIC STRENGTH : NULL; NULL; NULL REMARK 210 PRESSURE : AMBIENT; AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM H2O, 90% H2O/10% D2O; 1MM REMARK 210 D2O, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D DQF-COSY; 2D REMARK 210 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 800 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O DGN A 225 H ILE A 228 1.55 REMARK 500 N GLY A 1 CD CCS A 51 1.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 DGN A 225 64.60 160.64 REMARK 500 1 VAL A 226 -26.67 -37.62 REMARK 500 1 ARG A 248 -79.09 -102.29 REMARK 500 1 ARG A 249 -179.22 -59.34 REMARK 500 1 ARG A 251 34.41 -88.94 REMARK 500 1 ARG A 252 -34.42 -140.28 REMARK 500 1 THR A 273 -75.13 -84.97 REMARK 500 2 DGN A 225 64.87 161.35 REMARK 500 2 VAL A 226 -26.74 -37.16 REMARK 500 2 ARG A 248 -98.99 -69.54 REMARK 500 2 ARG A 249 -170.76 -63.54 REMARK 500 2 ARG A 251 39.94 -78.74 REMARK 500 2 THR A 273 -78.80 -84.14 REMARK 500 3 DGN A 225 65.77 160.65 REMARK 500 3 VAL A 226 -26.94 -37.42 REMARK 500 3 ARG A 243 -9.27 -55.50 REMARK 500 3 ALA A 244 -5.72 -156.22 REMARK 500 3 ARG A 248 -149.04 -95.89 REMARK 500 3 ARG A 249 -167.85 -58.06 REMARK 500 3 ARG A 251 43.60 -82.79 REMARK 500 3 THR A 273 -79.33 -83.87 REMARK 500 4 DGN A 225 65.98 160.56 REMARK 500 4 VAL A 226 -26.84 -37.70 REMARK 500 4 ARG A 243 0.39 -69.05 REMARK 500 4 ALA A 244 -5.53 -154.57 REMARK 500 4 ARG A 248 -134.81 -119.61 REMARK 500 4 ARG A 251 45.71 -79.79 REMARK 500 4 ARG A 252 -31.01 -135.56 REMARK 500 4 THR A 273 -78.30 -83.03 REMARK 500 5 DGN A 225 65.82 160.00 REMARK 500 5 VAL A 226 -26.93 -37.18 REMARK 500 5 ARG A 243 42.88 -76.88 REMARK 500 5 ALA A 244 -48.52 -143.10 REMARK 500 5 ARG A 247 -51.75 -29.53 REMARK 500 5 ARG A 248 -169.82 -114.80 REMARK 500 5 ARG A 249 161.30 -49.64 REMARK 500 5 ARG A 251 -126.47 -104.18 REMARK 500 5 THR A 273 -78.89 -84.65 REMARK 500 6 DGN A 225 65.67 161.63 REMARK 500 6 VAL A 226 -26.96 -37.52 REMARK 500 6 ARG A 243 41.14 -79.05 REMARK 500 6 ALA A 244 -62.33 -126.69 REMARK 500 6 ARG A 248 -85.22 -90.85 REMARK 500 6 ARG A 249 174.18 -56.69 REMARK 500 6 ARG A 251 40.97 -80.49 REMARK 500 6 ARG A 252 -35.01 -132.35 REMARK 500 6 THR A 273 -78.76 -84.29 REMARK 500 7 DGN A 225 67.54 160.54 REMARK 500 7 VAL A 226 -26.32 -37.59 REMARK 500 7 ARG A 248 -144.97 -69.10 REMARK 500 REMARK 500 THIS ENTRY HAS 136 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 52 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THESE ARE LINKER. THIO-ETHER BRIDGE BETWEEN CCS AND GLY WERE REMARK 999 CONSTRUCTED. DBREF 2JX4 A 225 273 UNP Q00788 V2R_RAT 225 273 SEQADV 2JX4 GLY A 1 UNP Q00788 SEE REMARK 999 SEQADV 2JX4 NLE A 266 UNP Q00788 MET 266 ENGINEERED MUTATION SEQADV 2JX4 NLE A 272 UNP Q00788 MET 272 ENGINEERED MUTATION SEQADV 2JX4 CCS A 51 UNP Q00788 SEE REMARK 999 SEQRES 1 A 52 GLY DGN VAL LEU ILE PHE ARG GLU ILE HIS ALA SER LEU SEQRES 2 A 52 VAL PRO GLY PRO SER GLU ARG ALA GLY ARG ARG ARG ARG SEQRES 3 A 52 GLY ARG ARG THR GLY SER PRO SER GLU GLY ALA HIS VAL SEQRES 4 A 52 SER ALA ALA NLE ALA LYS THR VAL ARG NLE THR CCS NH2 MODRES 2JX4 DGN A 225 GLN D-GLUTAMINE MODRES 2JX4 NLE A 266 LEU NORLEUCINE MODRES 2JX4 NLE A 272 LEU NORLEUCINE MODRES 2JX4 CCS A 51 CYS CARBOXYMETHYLATED CYSTEINE HET DGN A 225 17 HET NLE A 266 19 HET NLE A 272 19 HET CCS A 51 15 HET NH2 A 52 3 HETNAM DGN D-GLUTAMINE HETNAM NLE NORLEUCINE HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM NH2 AMINO GROUP FORMUL 1 DGN C5 H10 N2 O3 FORMUL 1 NLE 2(C6 H13 N O2) FORMUL 1 CCS C5 H9 N O4 S FORMUL 1 NH2 H2 N HELIX 1 1 DGN A 225 VAL A 237 1 13 HELIX 2 2 VAL A 237 ARG A 243 1 7 HELIX 3 3 THR A 253 CCS A 51 1 22 LINK N GLY A 1 CE CCS A 51 1555 1555 1.34 LINK C GLY A 1 N DGN A 225 1555 1555 1.33 LINK C CCS A 51 N NH2 A 52 1555 1555 1.33 LINK N CCS A 51 C THR A 273 1555 1555 1.33 LINK C DGN A 225 N VAL A 226 1555 1555 1.32 LINK C ALA A 265 N NLE A 266 1555 1555 1.31 LINK C NLE A 266 N ALA A 267 1555 1555 1.33 LINK C ARG A 271 N NLE A 272 1555 1555 1.32 LINK C NLE A 272 N THR A 273 1555 1555 1.33 SITE 1 AC1 6 GLY A 1 CCS A 51 PHE A 229 VAL A 270 SITE 2 AC1 6 ARG A 271 THR A 273 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1